missing translation for 'onlineSavingsMsg'
Learn More
Learn More
TLR3 Antibody (40C1285.6) - BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody has been used in 75 publications
Marca: Novus Biologicals NBP2-24875
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
TLR3 Monoclonal specifically detects TLR3 in Human, Mouse, Canine samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Flow (Intracellular), Bioactivity, Block/Neutralize.
Specifica
| TLR3 | |
| Monoclonal | |
| 1.0 mg/mL | |
| Western Blot 1-3 ug/ml, Flow Cytometry 2-4 ug/ 1x10^6 cells, Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence 1:10-1:500, Immunoprecipitation 2 ug/ 1x10^6 cells, Immunohistochemistry-Paraffin 1:10-1:500, Flow (Intracellular) reported in scientific literature (PMID 24836676), Bioactivity reported in scientific literature (PMID 28894449), Block/Neutralize reported in scientific literature (PMID 28894449) | |
| CD283, CD283 antigen, toll-like receptor 3 | |
| Mouse | |
| Protein G purified | |
| RUO | |
| Primary | |
| This antibody is reactive to Dog, Human and Mouse. | |
| Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
| IgG1 κ |
| Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin), Neutralization | |
| 40C1285.6 | |
| Unconjugated | |
| O15455 | |
| TLR3 | |
| A synthetic peptide corresponding to amino acids 55-85 of human TLR3 was used as immunogen. | |
| 0.1 mg | |
| Cytokine Research, Immune System Diseases, Immunology, Innate Immunity, Necroptosis, Signal Transduction, Toll Like Receptors | |
| 7098 | |
| Human, Mouse, Canine | |
| Purified |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
For Research Use Only
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto